Farallon Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Hold |
37,000
| – | – | ﹤0.01% | 89 |
|
|
2025
Q1 | $373K | Hold |
37,000
| – | – | ﹤0.01% | 94 |
|
|
2024
Q4 | $438K | Hold |
37,000
| – | – | ﹤0.01% | 93 |
|
|
2024
Q3 | $427K | Sell |
37,000
-636,000
| -95% | -$7.34M | ﹤0.01% | 104 |
|
|
2024
Q2 | $7.11M | Sell |
673,000
-225,600
| -25% | -$2.38M | 0.03% | 81 |
|
|
2024
Q1 | $9.47M | Sell |
898,600
-6,437,400
| -88% | -$67.9M | 0.04% | 89 |
|
|
2023
Q4 | $82.4M | Buy |
7,336,000
+3,482,600
| +90% | +$39.1M | 0.38% | 49 |
|
|
2023
Q3 | $45M | Buy |
3,853,400
+1,498,400
| +64% | +$17.5M | 0.21% | 59 |
|
|
2023
Q2 | $23.7M | Buy |
+2,355,000
| New | +$23.7M | 0.12% | 75 |
|